세계의 알레르기 치료 시장 보고서(2025년)
Allergy Treatment Global Market Report 2025
상품코드 : 1824326
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,482,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,370,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,257,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

알레르기 치료 시장 규모는 향후 수년간 강력한 성장이 전망됩니다. 2029년에는 CAGR 7.5%를 나타내 330억 1,000만 달러로 성장할 것으로 예상됩니다. 예측 기간의 성장은 환자 중심의 접근법, 시판(OTC) 알레르기 약물의 확대, 세계화와 도시화, 환경오염 증가, 건강보험에 대한 접근 증가 등에 기인한다고 생각됩니다. 예측 기간의 주요 동향으로는 진단기술의 향상, 면역요법의 진보, 약물전달의 기술 혁신, 제약기업간의 제휴, 신규 알레르기 치료법의 개발에 대한 제조업체의 투자 증가 등을 들 수 있습니다.

향후 5년간의 성장률 7.5%라고 하는 예측은 전회 예측으로부터 0.2%의 소폭의 감소를 반영하고 있습니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향 때문입니다. 관세 인상은 영국이나 캐나다에서 조달하는 에피네프린 자동 주사기와 류코트리엔 억제제의 가격을 밀어 올리고, 자기 부담액을 악화시켜, 긴급시의 약물의 입수를 제한함으로써, 미국의 환자에게 부담을 강하게 할 가능성이 높습니다. 또한 상호관세와 무역의 긴장과 한계 증가로 인한 세계경제와 무역에 대한 악영향으로 인해 그 영향이 더욱 광범위해질 것으로 보입니다.

알레르기 질환의 유병률 증가는 향후 알레르기 치료 시장 성장을 이끌 것으로 예측됩니다. 알레르기 증상은 면역계가 보통 무해한 물질인 알레르겐에 과다반응하여 발생합니다. 알레르기 치료에는 비 처방약과 처방약이 모두 있으며 알레르기의 방아쇠가 되는 다양한 물질을 확인하고 회피하여 알레르기 반응을 예방하고 증상을 완화하며 알레르기의 중증도를 줄이고 전신 건강을 증진합니다. 예를 들어, 2024년 4월 영국에 본부를 둔 전국적인 자선 단체인 Allergy UK는 영국에서는 2,100만 명 이상이 알레르기의 영향을 받았으며, 2022년에 가장 많이 보고된 만성 건강 상태라고 보고했습니다. 예측에 따르면 2026년까지 유럽 인구의 절반이 적어도 하나의 알레르기를 경험하게 될 전망입니다. 따라서 알레르기 질환의 유병률 증가는 알레르기 치료 시장 성장을 가속하고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

KTH
영문 목차

영문목차

Allergy treatment encompasses interventions designed to manage and alleviate allergic reactions and symptoms triggered by hypersensitivity to specific allergens. These treatments aim to mitigate or eliminate symptoms, improve overall quality of life, and prevent or reduce the occurrence of future allergic responses.

The primary modalities of allergy treatment include anti-allergy drugs and immunotherapy. Anti-allergic drugs are medications that prevent or alleviate allergic reactions, commonly used to treat symptoms arising from allergies by reducing or blocking histamines. Various types of allergies, such as eye allergy, skin allergy, food allergy, asthma, rhinitis, and others, may require different routes of administration, including oral, parenteral, nasal, among others. These treatments are distributed through channels such as hospital pharmacies, retail pharmacies, online retailers, catering to end-users such as hospitals, specialty clinics, home care, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The allergy treatment market research report is one of a series of new reports from The Business Research Company that provides allergy treatment market statistics, including allergy treatment industry global market size, regional shares, competitors with an allergy treatment market share, detailed allergy treatment market segments, market trends and opportunities, and any further data you may need to thrive in the allergy treatment industry. This allergy treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The allergy treatment market size has grown strongly in recent years. It will grow from $23.09 billion in 2024 to $24.74 billion in 2025 at a compound annual growth rate (CAGR) of 7.2%. The growth in the historic period can be attributed to increasing prevalence of allergies, increasing importance of self-medication, rise in healthcare spending, growing number of patients with various types of allergies.

The allergy treatment market size is expected to see strong growth in the next few years. It will grow to $33.01 billion in 2029 at a compound annual growth rate (CAGR) of 7.5%. The growth in the forecast period can be attributed to patient-centric approaches, expansion of over-the-counter (OTC) allergy medications, globalization and urbanization, rising environmental pollution, growing access to health insurance. Major trends in the forecast period include improved diagnostic technologies, advancements in immunotherapy, technological innovations in drug delivery, collaborations between pharmaceutical companies, rising investments by manufacturers on the development of novel allergic treatments.

The forecast of 7.5% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff escalations are likely to burden U.S. patients by driving up the cost of epinephrine auto-injectors and leukotriene inhibitors sourced from UK and Canada, exacerbating out-of-pocket expenses and limiting emergency medication availability. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing prevalence of allergic conditions is expected to drive the growth of the allergy treatment market in the future. An allergic condition occurs when the immune system overreacts to an allergen, which is typically a harmless substance. Allergy treatments include both nonprescription and prescription medications that help individuals identify and avoid various allergy triggers, thereby preventing allergic reactions, alleviating symptoms, reducing the severity of allergies, and enhancing overall well-being. For example, in April 2024, Allergy UK, a national charity based in the UK, reported that over 21 million people in the UK are affected by allergies, making them the most commonly reported chronic health condition in 2022. Projections suggest that by 2026, half of Europe's population will experience at least one allergy. Therefore, the increasing prevalence of allergic conditions is propelling the growth of the allergy treatment market.

The rise in environmental pollution is anticipated to boost the growth of the allergy treatment market in the coming years. Environmental pollution involves the introduction of contaminants and harmful substances into the natural environment, leading to negative effects on ecosystems, living organisms, and the overall quality of air, water, and soil. An increase in environmental pollutants raises individuals' vulnerability to allergic conditions, thereby intensifying the demand for effective allergy treatments. For instance, in June 2024, data published by the Office for National Statistics, a national statistical institute in the UK, indicated that UK greenhouse gas emissions increased by 1.2% from 2021 to 2022, reaching 506 million tonnes of carbon dioxide equivalent. Consumer expenditure accounted for 24.6% of these emissions, making it the largest contributor, followed by the energy sector at 16.4%. Therefore, the growing environmental pollution is driving the growth of the allergy treatment market.

Technological advancements stand out as a prominent and increasingly favored trend within the allergy treatment market. Key players in this market segment are embracing novel technologies to fortify their positions. In a notable instance, Metropolis Healthcare Limited launched AI-powered allergy component testing in May 2023, utilizing Component Resolved Diagnostics (CRD). This innovative testing method leverages artificial intelligence (AI) to assist physicians in making informed clinical decisions, providing crucial insights for optimizing personalized allergic disease treatment plans. Anchored by a nanotechnology-driven multiplex system, this approach identifies specific IgE antibodies against 295 distinct allergens through a straightforward blood test. It furnishes insights related to 158 food allergens, ten contact allergens, and 127 respiratory allergens.

Prominent entities operating within the allergy treatment market are actively involved in developing innovative products, notably nasal sprays, aimed at expanding their consumer base, driving sales, and augmenting revenue streams. Nasal sprays are liquid mist formulations administered through a spray mechanism into the nostrils. For instance, in August 2022, Hikma Pharmaceuticals PLC introduced RYALTRIS. This unique treatment solution caters to both adult and pediatric patients aged 12 and above, specifically targeting symptoms associated with seasonal allergic rhinitis (SAR). Distinguished as the sole fixed-dose combination therapy effectively addressing nasal and ocular SAR symptoms, RYALTRIS offers the convenience of a single nasal spray solution. Its standout attribute lies in delivering swift relief, noticeable nasal symptom improvement observed within a mere 15 minutes after the initial dose.

In January 2022, LifeMD Inc., a US-based telehealth technology company operating in the direct-to-patient space, successfully acquired Cleared for an undisclosed amount. This strategic acquisition is poised to broaden LifeMD's telehealth capabilities, enabling the company to extend its services from addressing lifestyle conditions to encompassing chronic illnesses with substantial market demand. Cleared, based in the United States, specializes in providing personalized care for allergies, asthma, and immunology.

Major companies operating in the allergy treatment market include Pfizer Inc., Johnson and Johnson, Allergy Therapeutics PLC, F. Hoffmann-La Roche Ltd, AbbVie Inc., Novartis AG, Merck & Co. Inc., Sanofi S.A., Thermo Fisher Scientific Inc., AstraZeneca, GlaxoSmithKline PLC, Eli Lilly and Company, Boehringer Ingelheim International GmbH, Regeneron Pharmaceuticals, Bausch Health Companies Inc., Teva Pharmaceutical Industries Ltd., Almirall S.A, Akorn Operating Company LLC, Alembic Pharmaceuticals Limited, ALK-Abello A/S, Stallergenes Greer International AG, Adamis Pharmaceuticals, HollisterStier Allergy, Leti Pharma SL

North America was the largest region in the allergy treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the allergy treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the allergy treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The allergy treatment market consists of revenues earned by entities by providing various therapies such as adjunct therapy, investigational therapies, immune modulation, immunotherapy (OIT), and sublingual immunotherapy (SLIT). The market value includes the value of related goods sold by the service provider or included within the service offering. The allergy treatment market also includes sales of nasal corticosteroids, antihistamines mast cell stabilizers, decongestants, corticosteroid creams or ointments, oral corticosteroids, and epinephrine. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Allergy Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on allergy treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for allergy treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The allergy treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Allergy Treatment Market Characteristics

3. Allergy Treatment Market Trends And Strategies

4. Allergy Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Allergy Treatment Growth Analysis And Strategic Analysis Framework

6. Allergy Treatment Market Segmentation

7. Allergy Treatment Market Regional And Country Analysis

8. Asia-Pacific Allergy Treatment Market

9. China Allergy Treatment Market

10. India Allergy Treatment Market

11. Japan Allergy Treatment Market

12. Australia Allergy Treatment Market

13. Indonesia Allergy Treatment Market

14. South Korea Allergy Treatment Market

15. Western Europe Allergy Treatment Market

16. UK Allergy Treatment Market

17. Germany Allergy Treatment Market

18. France Allergy Treatment Market

19. Italy Allergy Treatment Market

20. Spain Allergy Treatment Market

21. Eastern Europe Allergy Treatment Market

22. Russia Allergy Treatment Market

23. North America Allergy Treatment Market

24. USA Allergy Treatment Market

25. Canada Allergy Treatment Market

26. South America Allergy Treatment Market

27. Brazil Allergy Treatment Market

28. Middle East Allergy Treatment Market

29. Africa Allergy Treatment Market

30. Allergy Treatment Market Competitive Landscape And Company Profiles

31. Allergy Treatment Market Other Major And Innovative Companies

32. Global Allergy Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Allergy Treatment Market

34. Recent Developments In The Allergy Treatment Market

35. Allergy Treatment Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기